These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10989246)

  • 21. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
    Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
    J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An examination of adherence to pain medication plans in older cancer patients in hospice care.
    Sanders S; Herr KA; Fine PG; Fiala C; Tang X; Forcucci C
    J Pain Symptom Manage; 2013 Jan; 45(1):43-55. PubMed ID: 22841408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group.
    Greco MT; Corli O; Montanari M; Deandrea S; Zagonel V; Apolone G; ;
    Clin J Pain; 2011 Jan; 27(1):9-18. PubMed ID: 20842024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing breakthrough pain: a clinical review with three case studies using oral transmucosal fentanyl citrate.
    Rhiner M; Palos G; Termini M
    Clin J Oncol Nurs; 2004 Oct; 8(5):507-12. PubMed ID: 15515284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakthrough pain in the management of chronic persistent pain syndromes.
    Webster LR
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S116-22. PubMed ID: 18611099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
    Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
    J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough pain: definition and management.
    Portenoy RK; Hagen NA
    Oncology (Williston Park); 1989 Aug; 3(8 Suppl):25-9. PubMed ID: 2484297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pain: a descriptive study in patients with cancer.
    Matthie N; McMillan SC
    Clin J Oncol Nurs; 2014 Apr; 18(2):205-10. PubMed ID: 24675255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of treatment setting and patient characteristics on pain in terminal cancer patients: a report from the National Hospice Study.
    Morris JN; Mor V; Goldberg RJ; Sherwood S; Greer DS; Hiris J
    J Chronic Dis; 1986; 39(1):27-35. PubMed ID: 2418048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pain characteristics and management of inpatients admitted to a comprehensive cancer centre: a cross-sectional study.
    Kurita GP; Tange UB; Farholt H; Sonne NM; Strömgren AS; Ankersen L; Kristensen L; Bendixen L; Grønvold M; Petersen MA; Nordly M; Christrup L; Niemann C; Sjøgren P
    Acta Anaesthesiol Scand; 2013 Apr; 57(4):518-25. PubMed ID: 23336265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical survey of controlled-release morphine sulphate for cancer pain relief in a Japanese hospice.
    Tsuneto S; Hayashi A; Miyazaki M; Kashiwagi T
    Postgrad Med J; 1991; 67 Suppl 2():S79-81. PubMed ID: 1758822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pain syndromes and etiologies in ambulatory AIDS patients.
    Hewitt DJ; McDonald M; Portenoy RK; Rosenfeld B; Passik S; Breitbart W
    Pain; 1997 Apr; 70(2-3):117-23. PubMed ID: 9150284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal sufentanil for cancer-associated breakthrough pain.
    Good P; Jackson K; Brumley D; Ashby M
    Palliat Med; 2009 Jan; 23(1):54-8. PubMed ID: 19144765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology of cancer pain].
    Andersen G; Sjøgren P
    Ugeskr Laeger; 1998 Apr; 160(18):2681-4. PubMed ID: 9599549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and demographic characteristics help explain variations in pain at the end of life.
    Strassels SA; Blough DK; Veenstra DL; Hazlet TK; Sullivan SD
    J Pain Symptom Manage; 2008 Jan; 35(1):10-9. PubMed ID: 17959344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer pain in the elderly hospice patient.
    Stein WM; Miech RP
    J Pain Symptom Manage; 1993 Oct; 8(7):474-82. PubMed ID: 7963774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Observational Research Study to Evaluate the Impact of Breakthrough Cancer Pain on the Daily Lives and Functional Status of Patients.
    Twomey F; O'Brien T; O'Reilly M; Bogan C; Fleming J
    Ir Med J; 2015 Jun; 108(6):174-6. PubMed ID: 26182800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breakthrough pain: characteristics and impact in patients with cancer pain.
    Portenoy RK; Payne D; Jacobsen P
    Pain; 1999 May; 81(1-2):129-34. PubMed ID: 10353500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the impact of breakthrough cancer pain.
    Burton B; Zeppetella G
    Br J Nurs; 2011 May 27-Jun 9; 20(10):S14, S16-9. PubMed ID: 21647006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.